Effect of local therapy for the treatment of superficial esophageal cancer in non-operative candidates

Diseases of the Esophagus

Volumn 21, Issue 8, 2008, Pages 673-678

  Greenstein, A J ^a   Wisnivesky, J P ^a   Litle, Virginia R ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Department of Cardiothoracic Surgery ^*  (United States)

Author keywords

Cancer; Esophagus; Local therapy; Prognosis; SEER

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CELL DESTRUCTION; CANCER MORTALITY; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; CAUTERIZATION; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; CRYOABLATION; ENDOSCOPIC THERAPY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; EXCISION; FEMALE; HIGH RISK PATIENT; HUMAN; LASER SURGERY; MAJOR CLINICAL STUDY; MALE; PHOTODYNAMIC THERAPY; POLYPECTOMY; PRIORITY JOURNAL; SUPERFICIAL CANCER; SURGICAL RISK; SURVIVAL TIME; TUMOR BIOPSY;

AGED; CARCINOMA; COHORT STUDIES; ENDOSCOPY; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; NEOPLASM STAGING; SEER PROGRAM; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES;

EID: 56349139586     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2008.00832.x     Document Type: Article

References (40)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun M J. Cancer statistics, 2007. CA Cancer J Clin 2007; 57: 43-66.
2. DeMeester S R. Adenocarcinoma of the esophagus and cardia: A review of the disease and its treatment. Ann Surg Oncol 2006; 13: 12-30.
3. Kubo A, Corley D A. Marked regional variation in adenocarcinomas of the esophagus and the gastric cardia in the United States. Cancer 2002; 95: 2096-102.
4. Howe H L, Wu X, Ries L A et al. Annual report to the nation on the status of cancer, 1975-2003, featuring cancer among U.S. Hispanic/Latino populations. Cancer 2006; 107: 1711-42.
5. Ward E, Jemal A, Cokkinides V, Singh G K, Cardinez C, Ghafoor A, Thun M. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin 2004; 54: 78-93.
6. Baquet C R, Commiskey P, Mack K, Meltzer S, Mishra S I. Esophageal cancer epidemiology in blacks and whites: Racial and gender disparities in incidence, mortality, survival rates and histology. J Natl Med Assoc 2005; 97: 1471-8.
7. Blot W J, Devesa S S, Kneller R W, Fraumeni J F, Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991; 265: 1287-9.
8. Eloubeidi M A, Mason A C, Desmond R A, El-Serag H B. Temporal trends (1973-1997) in survival of patients with esophageal adenocarcinoma in the United States: A glimmer of hope? Am J Gastroenterol 2003; 98: 1627-33.
9. Portale G, Hagen J A, Peters J H, Chan L S, DeMeester S R, Gandamihardja T A, DeMeester T R. Modern 5-year survival of resectable esophageal adenocarcinoma: Single institution experience with 263 patients. J Am Coll Surg 2006; 202: 588-96; discussion 596-8.
10. Luketich J D, Alvelo-Rivera M, Buenaventura P O et al. Minimally invasive esophagectomy: Outcomes in 222 patients. Ann Surg 2003; 238: 486-94; discussion 494-5.
11. Ciocirlan M, Lapalus M G, Hervieu V et al. Endoscopic mucosal resection for squamous premalignant and early malignant lesions of the esophagus. Endoscopy 2007; 39: 24-9.
12. Larghi A, Lightdale C J, Ross AS et al. Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma. Endoscopy 2007; 39: 1086-91.
13. Orringer M B, Marshall B, Chang A C, Lee J, Pickens A, Lau C L. Two thousand transhiatal esophagectomies: Changing trends, lessons learned. Ann Surg 2007; 246: 363-72; discussion 372-4.
14. Sanz L, Ovejero V J, Gonzalez J J, Laso C A, Azcano E, Navarrete F, Martinez E. Mortality risk scales in esophagectomy for cancer: Their usefulness in preoperative patient selection. Hepatogastroenterology 2006; 53: 869-73.
15. Bartels H, Stein H J, Siewert J R. Preoperative risk analysis and postoperative mortality of oesophagectomy for resectable oesophageal cancer. Br J Surg 1998; 85: 840-4.
16. Inoue H, Endo M, Takeshita K, Kawano T, Goseki N, Takiguchi T, Yoshino K. Endoscopic resection of early-stage esophageal cancer. Surg Endosc 1991; 5: 59-62.
17. Yang G R, Zhao L Q, Li S S, Qiu S L, Wang Y M, Jia J H. Endoscopic Nd:YAG laser therapy in patients with early superficial carcinoma of the esophagus and the gastric cardia. Endoscopy 1994; 26: 681-5.
18. Hulscher J B, Tijssen J G, Obertop H, van Lanschot J J. Transthoracic versus transhiatal resection for carcinoma of the esophagus: A meta-analysis. Ann Thorac Surg 2001; 72: 306-13.
19. Rice T W, Blackstone E H, Goldblum J R et al. Superficial adenocarcinoma of the esophagus. J Thorac Cardiovasc Surg 2001; 122: 1077-90.
20. Ponec R J, Kimmey M B. Endoscopic therapy of esophageal cancer. Surg Clin North Am 1997; 77: 1117-97.
21. Sibille A, Lambert R, Souquet J C, Sabben G, Descos F. Long-term survival after photodynamic therapy for esophageal cancer. Gastroenterology 1995; 108: 337-44.
22. Corti L, Skarlatos J, Boso C et al. Outcome of patients receiving photodynamic therapy for early esophageal cancer. Int J Radiat Oncol Biol Phys 2000; 47: 419-24.
23. Surveillance, Epidemiology, and End Results (SEER) Program public use data (1973-2000) [serial online]. Bethesda, MD: National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Cancer Statistics Branch; 2006.
24. Ries L A G, Harkins D, Krapcho M et al. SEER Cancer Statistics Review, 1975-2004. Bethesda, MD: National CHncer Institute. Available at: http://seer.cancer.gov/csr/1975_2003/, based on November 2006 SEER data submission, posted to the website, 2007.
25. Greene F L, Page D L, Fleming I D etal (eds). AJCC Cancer Staging. Manual, 6th edn. New York: Springer-Verlag, 2002.
26. Kaplan E L M P. Nonparametric estimation for incomplete observations. J Am Stat Assoc 1958; 53: 457-81.
27. Wisnivesky J P, McGinn T, Henschke C, Hebert P, Iannuzzi M C, Halm E A. Ethnic disparities in the treatment of stage I non-small cell lung cancer. Am J Respir Crit Care Med 2005; 171: 1158-63.
28. Blot W J, Devesa S S, Fraumeni J F, Jr. Continuing climb in rates of esophageal adenocarcinoma: An update. JAMA 1993; 270: 1320.
29. Blot W J, McLaughlin J K. The changing epidemiology of esophageal cancer. Semin Oncol 1999; 26: 2-8.
30. Devesa S S, Blot W J, Fraumeni J F, Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998; 83: 2049-53.
31. Brown L M, Devesa S S. Epidemiologic trends in esophageal and gastric cancer in the United States. Surg Oncol Clin N Am 2002; 11: 235-56.
32. Fujita H, Sueyoshi S, Yamana H et al. Optimum treatment strategy for superficial esophageal cancer: Endoscopic mucosal resection versus radical esophagectomy. World J Surg 2001; 25: 424-31.
33. Westerterp M, Koppert L B, Buskens C J et al. Outcome of surgical treatment for early adenocarcinoma of the esophagus or gastroesophageal junction. Virchows Arch 2005; 446: 497-504.
34. Dovidio J F, ed. Stereotyping. MA: MIT Press, 1999.
35. Einbinder L C, Schulman K A. The effect of race on the referral process for invasive cardiac procedures. Med Care Res Rev 2000; 57 (Suppl 1): 162-80.
36. Davis T C, Williams M V, Marin E, Parker R M, Glass J. Health literacy and cancer communication. CA Cancer J Clin 2002; 52: 134-49.
37. Smith Sehdev A E, Hutchins G M. Problems with proper completion and accuracy of the cause-of-death statement. Arch Intern Med 2001; 161: 277-84.
38. Kircher T, Nelson J, Burdo H. The autopsy as a measure of accuracy of the death certificate. N Engl J Med 1985; 313: 1263-9.
39. Warren J L, Klabunde C N, Schrag D, Bach P B, Riley G F. Overview of the SEER-Medicare data: Content, research applications, and generalizability to the United States elderly population. Med Care 2002; 40: IV-3-18.
40. Cooper G S, Virnig B, Klabunde C N, Schussler N, Freeman J, Warren J L. Use of SEER-Medicare data for measuring cancer surgery. Med Care 2002; 40: IV-43-8.